stockrowBiofrontera Inc. (BFRI) vs China Pharma Holdings, Inc. (CPHI)
- Biofrontera Inc. BFRI 0.81 0.00%
- China Pharma Holdings, Inc. CPHI 0.56 +5.66%
Biofrontera Inc. and China Pharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. China Pharma Holdings, Inc. is the larger, with a market value of $22.8M against $12.0M — 1.9× the size. Biofrontera Inc. grew revenue faster over the last twelve months: 17.8% against −11.0%. Biofrontera Inc. has the higher net margin (−13.8% vs −114.3%) and the lower return on invested capital (−69.5% vs −7.23%). Across the 18 metrics below, Biofrontera Inc. leads on 9 and China Pharma Holdings, Inc. on 9.
Valuation
Profitability
| Metric | BFRI | CPHI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 79.25% | 11.76% | 53.51% |
| Operating margin | (14.22%) | (111.84%) | 0.00% |
| Net margin | (13.78%) | (114.33%) | (2.45%) |
| Free cash flow margin | (17.17%) | (3.59%) | 0.00% |
| Return on equity | (988.35%) | (20.99%) | (0.80%) |
| Return on assets | (28.80%) | (15.30%) | (1.67%) |
| Return on invested capital | (69.45%) | (7.23%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack